Home Newsfeeds CIBC Upgrades HEXO to Neutral

CIBC Upgrades HEXO to Neutral

CIBC analyst John Zamparo upgrades HEXO (TSX:HEXO) from Underperformer to Neutral.

byBenzinga Newsdesk

December 16, 2022

1 minute read

CIBC analyst John Zamparo upgrades HEXO (TSX:HEXO) from Underperformer to Neutral.

Merck’s Keytruda Combo Therapy Hits Primary Goal In Patients With Rare Form Of Gastric Cancer

By Vandana Singh

June 16, 1:50 PM

Merck & Co Inc (NYSE: MRK) announced topline data from the Phase 3 KEYNOTE-811 trial of Keytruda (pembrolizumab) plus trastuzumab and chemotherapy for human epidermal growth factor receptor 2 (HER2)-positive advanced gastric or

MRK

Why This Microsoft Analyst Is Lowering Their Price Target Ahead Of Q1 Earnings

By AJ Fabino

October 20, 12:37 PM

Rosenblatt Securities has reduced revenue estimates and slashed its price target on Microsoft Corporation (NASDAQ: MSFT) ahead of the software giant's Oct. 25 earnings report, citing increasing foreign exchange headwinds.

MSFT

Shoals Technologies Picks Dominic Bardos As Finance Chief

By Akanksha Bakshi

August 15, 1:18 PM

Shoals Technologies Group, Inc (NASDAQ:SHLS) has appointed Dominic Bardos as Chief Financial Officer, effective October 3, 2022. Bardos has more…

HLLY

News

What’s Going On With Bed Bath & Beyond Stock Today

By Henry Khederian

April 3, 10:20 AM

Bed Bath & Beyond Inc (NASDAQ:BBBY) shares are trading lower by 6.53% to $0.40 Monday morning. The stock is trading lower on continued downward momentum after the company recently entered a $300 million at the market offering program and issued weak fourth-quarter

BBBY

CIBC Upgrades HEXO to Neutral

Related Posts

Merck’s Keytruda Combo Therapy Hits Primary Goal In Patients With Rare Form Of Gastric Cancer

Why This Microsoft Analyst Is Lowering Their Price Target Ahead Of Q1 Earnings

Shoals Technologies Picks Dominic Bardos As Finance Chief

What’s Going On With Bed Bath & Beyond Stock Today